Experiences With Complementary and Integrative Health Among People With Rheumatoid Arthritis and Systemic Lupus Erythematosus: a Qualitative Study.

Details

• Alternative Title:
  The Journal of Rheumatology, 2025, v. 52, no. 8: Experiences With Complementary and Integrative Health Among People With Rheumatoid Arthritis and Systemic Lupus Erythematosus: a Qualitative Study.
• Journal Article:
  The Journal of Rheumatology
• Personal Author:
  Patterson, Sarah L. ; Ruvalcaba, Denise ; Issa, Arbella ; Rai, Krish ; Katz, Patricia ; Koenig, Christopher J.
• Description:
  Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are chronic immune-mediated inflammatory diseases often complicated by persistent pain and fatigue, despite cutting-edge pharmacological treatments. Lifestyle medicine (LM) and complementary and integrative health (CIH) offer adjuvant therapies with the potential to alleviate these symptoms, but little is known about patients' experiences with these modalities.
  
  This qualitative study explored the use of LM and CIH among English- and Spanish-speaking patients with RA and SLE. We conducted 5 focus groups using an original semistructured interview guide to examine participants' experiences with, and barriers to using, LM and CIH. Group discussions were recorded, transcribed verbatim, translated, and analyzed in a multistep iterative process to identify frequencies and thematic trends.
  
  Thirty-nine participants with RA or SLE discussed using LM and CIH modalities to manage their disease in 130 mentions. Diet was the most frequently discussed LM modality, with participants noting specific foods that exacerbated or alleviated symptoms. Traditional Chinese medicine and natural products were the most-discussed CIH approaches, and participants expressed a strong interest in exploring additional CIH modalities to mitigate symptoms. The primary barriers to using LM and CIH were uncertainty regarding safe and effective practices and high out-of-pocket expenses.
  
  Patients with RA and SLE are highly interested in using LM and CIH to manage their conditions, but many are unsure which adjunctive treatment approaches are safe and effective. More research on LM and CIH modalities is needed to facilitate clear, evidence-based answers to these common patient questions.
• Content Notes:
  Author manuscript
• Subjects:
  • Humans
  • Lupus Erythematosus, Systemic
  • Arthritis, Rheumatoid
  • Female
  • Male
  • Complementary Therapies
  • Qualitative Research
  • Middle Aged
  • Adult
  • Focus Groups
  More +
• Keywords:
  • Qualitative Research
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • Lifestyle Medicine
  • Complementary
  • Integrative Health
• Source:
  The Journal of Rheumatology, 2025, v. 52, no. 8
• DOI:
  https://doi.org/10.3899/jrheum.2024-1218
• ISSN:
  0315-162X ; 1499-2752
• Pubmed ID:
  40312102
• Pubmed Central ID:
  PMC12317831
• Document Type:
  Text
• Funding:
  K23 AT011768/AT/NCCIH NIH HHSUnited States/ ; U01 DP005120/DP/NCCDPHP CDC HHSUnited States/ ; U01 DP006701/DP/NCCDPHP CDC HHSUnited States/
• Genre:
  Journal Article
• Pages in Document:
  758-769 (20 pdf pages)
• Volume:
  52
• Issue:
  8
• Download URL:
  https://stacks.cdc.gov/view/cdc/261443/cdc_261443_DS1.pdf
• File Type:
  [PDF - 132.60 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:2160d5659b64b20737ea0996b6674cef1a914d3478539ba859094a7d7baed9a810b8c292ea4ddadaf7e0fa4479f10c2822db21f0090bb4bd0c11ca8e789a4473